<DOC>
	<DOCNO>NCT00322816</DOCNO>
	<brief_summary>The purpose pilot study evaluate use ( 1 ) 'malaria prevalence ' , ( 2 ) 'malaria incidence ' ( 3 ) 'malaria mortality ' measure malaria transmission The Gambia , mosquito insecticide ( larvicide ) use control malaria-carrying mosquito . Two thousand child age 6 month 10 year age recruit village study area . They monitor 7 month presence malaria parasites sign symptom disease .</brief_summary>
	<brief_title>Malaria Prevalence Children</brief_title>
	<detailed_description>Malaria remain one world 's great childhood killer substantial obstacle social economic development tropic . The overwhelming bulk world 's malaria burden rest upon population sub-Saharan Africa unique coincidence expand human population , weak health system , world 's effective vector mosquito specie environmental condition ideal transmission . At start new millennium malaria still deeply entrenched Africa effective malaria control threat inexorable spread parasite strain resistant antimalarial drug emergence mosquito resistant pyrethroid insecticide use impregnate bednets . Larval control may offer new alternative effective control . We plan apply larvicide effort control malaria reduce burden malaria . While abundantly clear product kill mosquito larvae laboratory field , certain reduce burden malaria human population . There several step intervene survival mosquito larvae aquatic breeding site human end point hope achieve . Briefly , step involve include survival development immature mosquito stage , emergence adult mosquito , blood feeding mosquito , acquisition development malaria parasite adult mosquito transmission parasites susceptible human . Once infected , human population may either clear infection time go develop symptom . Among develop symptom , receive prompt successful treatment , others go either develop chronic symptom progress severe malaria death . Primary outcome : 1 ) proportion subject malaria parasite ( Plasmodium Falciparum ) , 2 ) incidence clinical malaria , 3 ) age-standardized overall malaria-specific mortality . Secondary outcome : 1 ) prevalence clinical episode malaria ( presence malaria parasites plus axillary temperature 37.5 C great examination history fever last 48 hour ) ; 2 ) prevalence high parasitemia ( define equal great 5000 parasite per mcl ) ; 3 ) prevalence enlarge spleen ( define use Hackett 's classification ) ; 4 ) prevalence severe anemia ( define hemoglobin less equal 5 g/dl ) . Within broad area eastern Gambia , zone identify application larvicide , match control zone larval control apply . In area , human population monitor determine whether one four specific malariometric end point provide valid assessment larvicidal effectiveness . In study 2000 child , 6 month 10 year age , recruit . These pilot study inform subsequent ( included NIH project ) large scale evaluation larviciding malaria control . This protocol design determine whether prevalence incidence malaria attack death use evaluate impact Bti malaria transmission control .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Malaria , Falciparum</mesh_term>
	<criteria>All child live define area intervention age 6 month 10 year invited participate . No distinction make regard gender ethnic group . Moreover , target population people live area intervention , order result study generalizable possible , distinction make term medical condition physical health . Moreover , believe child medical condition would especially favor participation study .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>Malaria , Plasmodium falciparum , Gambia , larvicide</keyword>
</DOC>